Huntsman Corporation (HUN) | The Buildout — AI Infrastructure

The Verdict

Huntsman makes the chemistry that goes into a broad set of industrial and building products: polyurethane systems built on MDI, amines and maleic anhydride intermediates, and formulated advanced-materials polymers. In the AI build-out it sits several steps removed. It supplies material for electrical grid equipment, rigid polyurethane and PIR insulation boards used in data centers and warehouses, and high-purity amines used in semiconductor manufacturing. None of those is a separate product line with disclosed revenue, and management raises AI only as one reason grid power demand is rising. The company's own strategic conversation is about MDI cycles, European energy and the Olin merger.

Earnings

Huntsman reported Q2 2026 revenue of $1,663M, up from $1,420M in Q1 2026 and $1,458M a year earlier. Gross margin was 14.7%, against 12.9% in Q1 and 12.5% in the prior-year quarter, and EBITDA was $111M, a 6.7% margin. Net loss attributable to Huntsman was $6 million, versus a $158 million loss a year earlier, and adjusted net income was nil. Management said Advanced Materials volume grew 8% and Polyurethanes volume 4%, both described as in excess of underlying markets.

Management tone: The tone moved in two directions at once. On the macro it got darker: Q1 2026 language was "stronger than expected demand," while on the Q2 2026 call the CEO said he remained concerned about consumer confidence growth, noted softened North American housing and languishing Chinese consumer confidence, and put MDI demand growth at only 0%–2%. Management also lowered its MDI utilization framing from the high 80s to the mid-80s and cut construction growth language to "very gradual." On the merger and on pricing the register was unhedged — "1 and 1 make 3" — alongside an acknowledgement that investors are in a "show me" posture on synergies. Management talked its own positives down too: a competitor polyol outage benefit of only low $2–3 million, and an aerospace pull-forward described as "de minimis." One claim went unreconciled on the call: that MDI EBITDA had nearly doubled year over year, against a company-level $6 million net loss and nil adjusted income.

Management Guidance

Management gave specific figures rather than a company-wide range. On the merger it disclosed roughly $300 million of cost synergies — about $75 million purchasing and logistics, about $75 million epoxy overlap and integration, and $150 million SG&A, with the SG&A piece described as "imminently achievable" and the vast majority of the $300 million expected over a roughly two-year basis after close — plus a separate $100 million-plus from replacing external chlorine with internal Olin supply, anchored for the largest Americas contract after it ends at the end of 2030. For 2026 it reaffirmed $45 million of in-year cost savings and said capital expenditures should be similar to 2025. It said it is moving toward roughly 4x net leverage through the second half of 2026, from 5.4x in Q2, and continues to expect Europe to be EBITDA positive in Q3 2026, with European gas above $20/MMBtu flagged as its biggest concern for the region. Specialty amines were guided at $5-plus million in 2026, against a nine-to-twelve-month qualification clock and a target of a normalized run rate "hopefully by the end of the year." Management also confirmed the assumptions behind an S-4 2027 EBITDA projection of roughly $500 million but did not restate the number.

Trajectory

Revenue has climbed from $1,355M in Q4 2025 to $1,420M in Q1 2026 and $1,663M in Q2 2026 — a 17.1% sequential increase that the code-computed read labels accelerating. Gross margin was 14.7% in Q2 2026, against 12.5% a year earlier, and EBITDA margin was 6.7% against 4.2%. The company-level swing is large on its own definition: an adjusted net loss of $(35) million in Q1 2026 became nil adjusted income in Q2. Management attributes the improvement to price-over-cost discipline and mix rather than volume — Advanced Materials and Polyurethanes both grew volume faster than their underlying markets while MDI demand grew only 0%–2%. Trailing twelve-month revenue is $5,898M at 0.6% growth, with EBITDA of $290M (4.9%) and free cash flow of -$9M.

The Model

The model projects FY+1 revenue of $6,245M with EBITDA of $368M, a 5.9% margin, and FY+2 revenue of $6,500M with EBITDA of $500M, a 7.7% margin. The near-term anchor is the price-over-cost and mix story already running: roughly a 5.9% revenue step-up in FY+1 off the $5,898M trailing base, with margin expanding by less than a percentage point. FY+2 embeds the larger margin move, with EBITDA rising about $132M on roughly $255M of additional revenue, consistent with the S-4 assumptions management confirmed — moderate economic improvement, a gradual housing recovery, and continued power and aerospace growth in Advanced Materials.

Projections are the median of 5 independent model runs. The model’s revenue sits 4.1% above analyst consensus.

Management gave specific figures rather than a company-wide range. On the merger it disclosed roughly $300 million of cost synergies — about $75 million purchasing and logistics, about $75 million epoxy overlap and integration, and $150 million SG&A, with the SG&A piece described as "imminently achievable" and the vast majority of the $300 million expected over a roughly two-year basis after close — plus a separate $100 million-plus from replacing external chlorine with internal Olin supply, anchored for the largest Americas contract after it ends at the end of 2030. For 2026 it reaffirmed $45 million of in-year cost savings and said capital expenditures should be similar to 2025. It said it is moving toward roughly 4x net leverage through the second half of 2026, from 5.4x in Q2, and continues to expect Europe to be EBITDA positive in Q3 2026, with European gas above $20/MMBtu flagged as its biggest concern for the region. Specialty amines were guided at $5-plus million in 2026, against a nine-to-twelve-month qualification clock and a target of a normalized run rate "hopefully by the end of the year." Management also confirmed the assumptions behind an S-4 2027 EBITDA projection of roughly $500 million but did not restate the number.

What Could Go Right — and Wrong

Looking Ahead

Over the next twelve months the operating story is a slow climb: price held above cost, mix moving toward the higher-margin segment, leverage coming down toward roughly 4x, and demand management itself describes as stable rather than recovering. The structural event is the Olin merger — approved by shareholders on 2026-08-25 and past its HSR waiting period on 2026-09-11, with a close expected in H1 2027 per Olin's commentary. Nothing in the material suggests AI changes the plan; the company's AI-adjacent line, specialty amines, is a $5-plus million item and went without an update on the latest call.

Financials

Annual Summary

Key Ratios (Trailing)

The Company

Huntsman is a global manufacturer of diversified organic chemicals, operating in three segments. Polyurethanes produces MDI, polyols and TPU, which combine into formulated systems sold into insulation, adhesives, elastomers and automotive and building products. Performance Products makes amines and maleic anhydride for a wide range of consumer and industrial end markets. Advanced Materials formulates epoxy, phenoxy, acrylic, polyurethane, mercaptan and acrylonitrile butadiene-based polymer products, plus carbon nanomaterials, for aerospace, electronics, coatings and electrical infrastructure. It buys commodity feedstocks such as benzene, chlorine, caustic, natural gas and propylene, and sells formulated chemistry and intermediates into construction, industrial, automotive, aerospace, electronics, coatings and agricultural markets.

Huntsman operates 18 named sites across the U.S., Europe, China, Saudi Arabia and Switzerland. Three MDI plants — Geismar, Louisiana; Rotterdam, Netherlands; and Caojing, China — anchor Polyurethanes, and on the Q1 2026 call management said the Chinese operation was sold out completely and the U.S. operation was, for the most part, sold out. Performance Products runs amine plants at Freeport, Port Neches, Conroe and Jubail plus maleic anhydride at Pensacola, Florida. Advanced Materials is a formulating and synthesis network rather than a heavy-manufacturing one — six formulation sites and two technology centers. Management's stated strategy is to push more of its own molecules downstream into higher-value formulated products.

Business Segments

Competitive Landscape

The 10-K names competitors across every segment and sub-market, from BASF, Covestro, Dow, Lubrizol and Wanhua Chemical Group in MDI to a separate set of rivals in each Advanced Materials application. That is a crowded, global competitive set of large chemical majors. Management is explicit about the constraint it creates: about 40% of Americas contracts are formula-based on six- to twelve-month repricing cycles, and the CEO says contract structure is "largely dictated by competition." The 10-K also warns that raw-material and energy cost increases may be "unable to pass on to our customers."

Supply Chain

Huntsman sits mid-chain, buying commodity feedstocks and selling formulated chemistry. Its most consequential input relationship is Olin — supplier of chlorine-chain materials, MDI competitor and now merger partner. Of the neighbors reviewed, only Olin names Huntsman directly.